126 related articles for article (PubMed ID: 18556231)
1. Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: a retrospective 35-year study of 12 patients.
Bégu-Le Corroller A; Valéro R; Moutardier V; Henry JF; Le Treut YP; Gueydan M; De Micco C; Sierra M; Conte-Devolx B; Oliver C; Raccah D; Favre R; Digue L; Heim M; Seitz JF; Delpero JR; Vialettes B
Diabetes Metab; 2008 Sep; 34(4 Pt 1):343-8. PubMed ID: 18556231
[TBL] [Abstract][Full Text] [Related]
2. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
4. Liver metastases 9 years after removal of a malignant insulinoma which was initially considered benign.
Gonzalez-Gonzalez A; Recio-Cordova JM
JOP; 2006 Mar; 7(2):226-9. PubMed ID: 16525209
[TBL] [Abstract][Full Text] [Related]
5. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999].
Mignon M
Bull Acad Natl Med; 2003; 187(7):1249-58; discussion 1259-60. PubMed ID: 15146602
[TBL] [Abstract][Full Text] [Related]
7. [Malignancy: treatment and prognosis of gastrointestinal and pancreatic endocrine neoplasia: retrospective study of a series of 16 cases].
Pansini GC; Lanzara S; Feo CV; Zamboni P; Liboni A; Ambrosio MR; Marzola A; Feggi L
Ann Ital Chir; 2001; 72(4):413-21; discussion 422. PubMed ID: 11865693
[TBL] [Abstract][Full Text] [Related]
8. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
9. Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.
Scigliano S; Lebtahi R; Maire F; Stievenart JL; Kianmanesh R; Sauvanet A; Vullierme MP; Couvelard A; Belghiti J; Ruszniewski P; Le Guludec D
Endocr Relat Cancer; 2009 Sep; 16(3):977-90. PubMed ID: 19470616
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of pancreatic insulinoma].
Priego P; Sanjuanbenito A; Martínez Molina E; Lobo E; García Teruel D; Morales V; Rodríguez G; Fresneda V
Rev Esp Enferm Dig; 2007 Apr; 99(4):218-22. PubMed ID: 17590104
[TBL] [Abstract][Full Text] [Related]
11. A rare surgical case of multiple liver resections for recurrent liver metastases from pancreatic gastrinoma: liver and vena cava resection.
Pachera S; Yokoyama Y; Nishio H; Oda K; Ebata T; Igami T; Abe T; Shingu Y; Nagino M
J Hepatobiliary Pancreat Surg; 2009; 16(5):692-8. PubMed ID: 19267257
[TBL] [Abstract][Full Text] [Related]
12. [Clinical experience in diagnosis and treatment of glucagonoma].
Liu WJ; Zhao YP; Zhang TP; Liao Q; Cong L
Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(5):333-6. PubMed ID: 19595005
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
14. Malignant metastatic insulinoma-postoperative treatment and follow-up.
Starke A; Saddig C; Mansfeld L; Koester R; Tschahargane C; Czygan P; Goretzki P
World J Surg; 2005 Jun; 29(6):789-93. PubMed ID: 15880279
[TBL] [Abstract][Full Text] [Related]
15. Endocrine tumors of the ileum: factors correlated with survival.
Tomassetti P; Campana D; Piscitelli L; Casadei R; Nori F; Brocchi E; Santini D; Pezzilli R; Corinaldesi R
Neuroendocrinology; 2006; 83(5-6):380-6. PubMed ID: 17016032
[TBL] [Abstract][Full Text] [Related]
16. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
17. [Radiofrequency ablation of colorectal liver metastases].
Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
[TBL] [Abstract][Full Text] [Related]
18. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
[TBL] [Abstract][Full Text] [Related]
19. Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.
Elias D; Goéré D; Leroux G; Dromain C; Leboulleux S; de Baere T; Ducreux M; Baudin E
Eur J Surg Oncol; 2009 Oct; 35(10):1092-7. PubMed ID: 19464140
[TBL] [Abstract][Full Text] [Related]
20. Strategy for pancreatic endocrine tumors.
Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Demachi H; Miwa A
Hepatogastroenterology; 2000; 47(32):537-9. PubMed ID: 10791232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
